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Methods Data was retrospectively collected from three 
patients admitted with MERS-CoV infection to Intensive 
Care unit (ICU) at King Abdulaziz Medical City, Riyadh. 
They were managed separately in three different wards 
prior to their admission to ICU.
Finding The three patients presented with severe neuro-
logic syndrome which included altered level of conscious-
ness ranging from confusion to coma, ataxia, and focal 
motor deficit. Brain MRI revealed striking changes char-
acterized by widespread, bilateral hyperintense lesions on 
T2-weighted imaging within the white matter and subcor-
tical areas of the frontal, temporal, and parietal lobes, the 
basal ganglia, and corpus callosum. None of the lesions 
showed gadolinium enhancement.
Abstract 
Background Since the identification of the first case of 
infection with the Middle East respiratory syndrome corona 
virus (MERS-CoV) in Saudi Arabia in June 2012, the num-
ber of laboratory-confirmed cases has exceeded 941 cases 
globally, of which 347 died. The disease presents as severe 
respiratory infection often with shock, acute kidney injury, 
and coagulopathy. Recently, we observed three cases who 
presented with neurologic symptoms. These are so far the 
first reported cases of neurologic injury associated with 
MERS-CoV infection.
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Interpretation CNS involvement should be considered in 
patients with MERS-CoV and progressive neurological dis-
ease, and further elucidation of the pathophysiology of this 
virus is needed.
Keywords Middle East respiratory syndrome 
corona virus · Encephalitis · Acute disseminated 
encephalomyelitis · Stroke · Pneumonia · Acute respiratory 
distress syndrome
Introduction
Since the identification of the first case of infection with the 
Middle East respiratory syndrome corona virus (MERS-
CoV) in Saudi Arabia in June 2012 [1], the number of 
laboratory-confirmed cases has exceeded 941 cases glob-
ally, of which 347 died [2]. The disease presents as severe 
respiratory infection often with shock, acute kidney injury, 
and coagulopathy [3]. We recently have reported the clinical 
manifestations and outcome in 12 patients with MERS-CoV 
infection admitted to the intensive care unit (ICU) [4]. Here 
we report three cases presenting with severe neurologic syn-
drome. To our knowledge, these are the first identified cases 
of neurologic injury associated with MERS-CoV infection.
Methods
Setting
Three patients from King Abdulaziz Medical City in 
Riyadh presented from the community in February and 
March 2014. They were admitted to different wards and 
were managed separately prior to admission to the ICU. 
There was no hospital transmission of MERS-CoV among 
healthcare workers during their hospitalization. Approval to 
collect data for these patients and report them was obtained 
from the Institutional Review Board of the Ministry of 
National Guard-Health Affairs. The consent was waived 
because of the observational nature of the study as per the 
institutional policy.
Patients
The clinical course as well as the laboratory and radio-
logical findings of three patients with community-acquired 
MERS-CoV and progressive neurological findings were 
assessed by reviewing medical records and interviewing the 
managing team. Testing for MERS-CoV was performed by 
real-time reverse transcription polymerase chain reaction 
(RT-PCR) as described in the online supplement.
Patient 1
A 74-year-old Saudi male patient with diabetes, hyperten-
sion, and dyslipidemia presented with a 3 days of ataxia, 
vomiting, confusion, and fever of 39.5 °C (Fig. 1). Exami-
nation revealed dysmetria and decreased motor power on 
the left side. Chest radiograph showed infiltrate in the mid 
right lung zone. Computerized tomography (CT scan) of 
the brain showed multiple chronic lacunar strokes but no 
acute changes. He was admitted to the ward with a work-
ing diagnosis of community-acquired pneumonia and pos-
sible stroke and was started on broad-spectrum antibiotics, 
and required no intensive care at that time. Because of his 
neurologic symptoms, brain magnetic resonance imaging 
(MRI) on hospital day (HD) 5 was obtained and showed 
moderate chronic small vessel ischemic changes (Fig. 2).
On HD 7, he was referred to the critical care response 
team because of increasing dyspnea and hypoxia, persistent 
fever, and progression in air space disease on chest radio-
graphs (Online Figure 1) and was started on oseltamivir, 
bronchodilators, and methylprednisolone. MERS-CoV RT-
PCR was sent from tracheal aspirate according to guide-
lines for management of critically ill patients with lower 
repertory illness and returned positive. Further history 
revealed exposure to camels. On HD 9, he was transferred 
to the ICU, where he was awake but severely hypoxic with 
oxygen saturation of 68–75 % on 100 % oxygen via non-
rebreather mask. During his ICU stay, patient was man-
aged as a case of severe acute respiratory distress syndrome 
(ARDS), which required intubation and mechanical ven-
tilation by lung protective strategy, intravenous sedation, 
neuromuscular blockers, prone positioning, and inhaled 
nitric oxide. He required vasopressors and continuous renal 
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replacement therapy. On HD 11, he was given peginter-
feron alpha-2b and ribavirin [5]. Subsequent MERS-CoV 
tests were positive until HD 28 (Fig. 1).
On HD 24, his respiratory status improved and trache-
ostomy was performed. However, he remained comatose 
with Glasgow Coma Scale of 3–4; and a repeat CT scan 
of the brain showed an interval development of numerous 
patchy hypodensities in the periventricular deep white mat-
ter and subcortical region, bilateral basal ganglia, thalami, 
pons, cerebellum, and cerebellar pedicles in addition to a 
large hypodensity in the splenium and posterior body of the 
corpus callosum. MRI identified multiple bilateral patchy 
areas of signal abnormality that appeared high on T2/
FLAIR images seen in the periventricular, deep white mat-
ter, subcortical area, corpus callosum, bilateral brachium 
pontis, midbrain as well as in the left cerebellum and upper 
cervical cord. The lesions were non-enhancing and showed 
diffusion restriction (Fig. 2).
Cerebrospinal fluid (CSF) analysis showed a white 
cell count of 1 cell and protein of 0.56 g/L (reference 
0.15–0.40 g/L) and negative MERS-CoV RT-PCR. The 
patient had lymphopenia throughout his illness (Online 
Figure 2). Lymphocyte subset analysis revealed critically 
low absolute CD4 and CD8 count with a normal ratio 
(Table 1). Other tests are available online. Due to deep 
coma, poor overall condition and worsening cardiovascular 
and respiratory status, he expired on HD 34.
Patient 2
A 57-year-old diabetic, hypertensive, Saudi male with 
peripheral vascular disease presented with 3 days of flu-like 
illness, fever (39.0 °C), and a gangrenous toe. His working 
diagnosis was diabetic foot and was empirically started on 
broad-spectrum antibiotics. On HD 2 he developed acute 
myocardial ischemia with pulmonary edema (Online Fig-
ure 1) for which he was intubated. An emergency coronary 
angiography revealed chronic severe 3-vessel disease with 
no acute vessel closure (Fig. 1). Troponin level peaked to 
13.5 ng/mL at 12 h and his electrocardiogram returned to 
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Fig. 1  Timeline of pertinent events and MERS-CoV RT-PCR results 
in patients 1, 2, and 3. MRI Magnetic resonance imaging, CCRT criti-
cal care response team, ICU intensive care unit, RRT renal replace-
ment therapy, TA tracheal aspirate, BAL bronchoalveolar lavage, CSF 
cerebrospinal fluid, NSTEMI non-ST elevation myocardial infarction, 
GI gastrointestinal
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normal within 48 h consistent with non-ST elevation myo-
cardial infarction (NSTEMI). He was extubated on HD 4 
but 2 h later he became unresponsive, hypotensive with 
left-sided facial paralysis, and required reintubation. Brain 
CT scan showed two subtle hypodensities seen at the right 
semiovale and left basal ganglia likely representing small 
lacunar infarctions. CT angiography showed near total 
occlusion at the origin of both internal carotid arteries with 
intracranial narrowing of the left middle cerebral artery 
at M1 segment and intact anterior communicating artery, 
Fig. 2  Magnetic resonance imaging (MRI) of the three patients. 
Patient 1—First MRI—day 5: a Diffusion weighted imaging (DWI) 
and Apparent Diffusion Coefficient (ADC) mapping showed patchy 
non-specific signal changes with no restriction. Further images were 
not obtained because patient could not tolerate the test. Patient 1—
Second MRI—day 28: b Diffusion weighted imaging (DWI) and 
Apparent Diffusion Coefficient (ADC) mapping showed diffusion 
restriction of the multiple white matter lesions. c Axial fluid-attenu-
ated inversion recovery (FLAIR) images showed multiple hyperin-
tense lesions in the subcortical areas and deep white matter of frontal, 
temporal, and parietal lobes bilaterally as well as in the corpus cal-
losum. d Axial contrast enhanced T1-weighted (T1Wl) showed mul-
tiple subcortical areas and deep white matter non-enhancing lesions. 
Patient 2—Day 8: e DWI and ADC mapping showed diffusion 
restriction of the bilateral frontal and corpus callosum lesions. f Axial 
FLAIR images showed bilateral confluent subcortical areas and deep 
white matter hyperintense lesions in the frontal lobes, basal ganglia, 
and corpus callosum. g Coronal T2 images showed bilateral hyperin-
tense white matter lesions in the frontal lobes and in the corpus cal-
losum. Patient 3—Day 25: h Axial FLAIR Images showing diffuse 
white matter (deep) signal abnormality at the insular region bilater-
ally. i Coronal T2-weighted images showing abnormality involving 
corticospinal tract bilaterally extending to the brain stem
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and bilateral anterior cerebral arteries (ACA) with no 
radiographic features of vasculitis. (Online Figure 3). On 
HD 6, he had recurrence of fever with leukopenia (WBC 
3.2 × 109) and a respiratory sample for MERS-CoV tested 
positive. On HD 8, repeat brain CT scan showed interval 
multiple patchy hypodensities bilaterally in the periven-
tricular, deep white matter and bilateral basal ganglia, and 
a large area of hypodensity in the proximal half of the cor-
pus callosum up to the mid part of his body. MRI showed 
signal abnormality bilaterally in the deep watershed and in 
the parasagittal region as well as scattered foci in the cor-
tical and subcortical regions of the temporal, parietal, and 
occipital lobes with restriction on the diffusion weighted 
images (DWI) consistent with acute infarction (Fig. 2). On 
HD 9, his condition progressed to severe shock and acute 
kidney injury, had multiple cardiac arrests and expired. No 
CSF samples were taken on this patient.
Patient 3
A 45-year-old diabetic, hypertensive Saudi male with 
chronic kidney disease and ischemic heart disease pre-
sented with a 10-day history of productive cough, dysp-
nea, rigors, fever, and diarrhea with no significant travel or 
animal exposure. He was conscious and had no focal neu-
rological findings. Chest radiograph showed an infiltrate 
in the lower and mid right zones. He was admitted with a 
working diagnosis of community-acquired pneumonia and 
acute kidney injury. He was started on broad-spectrum 
antibiotics, oseltamivir, and renal replacement therapy. 
On HD 2, he required intubation and ICU admission for 
severe ARDS, which was managed by a lung protective 
strategy, intravenous sedation, neuromuscular blockers, 
and nitric oxide. He required vasopressors and continuous 
renal replacement therapy. His tracheal aspirate tested posi-
tive for MERS-CoV and no other pathogens were detected. 
On HD 9, he was given peginterferon alpha-2b and riba-
virin [5]. Subsequent MERS-CoV tests from respiratory 
samples were positive (Fig. 1). He recovered from septic 
shock and respiratory failure, and had tracheostomy placed 
on HD 24. Because of low Glasgow Coma Scale and fever, 
brain CT scan was performed and showed no acute abnor-
mality. MRI showed confluent T2WI/FLAIR hyperinten-
sity within the white matter of both cerebral hemispheres 
and along the corticospinal tract. There was no diffusion 
restriction or abnormal enhancement after administration 
of contrast. These findings were considered to be consistent 
with encephalitis. CSF analysis showed a white cell count 
of 2 cells, and protein of 0.85 g/L with negative MERS-
CoV RT-PCR. Other tests are listed in the online supple-
ment. Lymphocyte counts were low (Online Figure 2) and 
lymphocyte subsets were markedly reduced (Table 1). This 
patient was discharged home on HD 107.
Discussion
Three patients were admitted with 3 different working 
diagnoses with fever as one of the initial symptoms. Each 
eventually developed symptoms raising an index of sus-
picion for MERS-CoV infection, which was confirmed 
by RT-PCR. In addition, all had neurologic symptoms: at 
presentation for patient 1 and on HD 5 and 24 for patients 
2 and 3, respectively. The neurologic manifestations 
included altered mental level ranging from confusion to 
coma, ataxia, and focal motor deficits. Given the significant 
comorbidities and the severe critical illness, such neuro-
logical findings may easily be attributed to other common 
etiologies. However, the striking findings of the MRI from 
our first patient raised the concern for critically examin-
ing the subsequent two patients. Brain MRI revealed new-
onset widespread, bilateral hyperintense lesions on T2WI 
within the white matter and subcortical areas of the fron-
tal, temporal, and parietal lobes, the basal ganglia and cor-
pus callosum, pons, cerebellum, and upper cervical cord. 
None enhanced with gadolinium. CSF examination in two 
patients was unremarkable with the exception of increased 
protein level. Besides the neurological manifestations, the 
three patients had several things in common; all had other 
organ dysfunctions involving respiratory, renal, and car-
diovascular systems, all had persistent viral shedding from 
Table 1  Lymphocyte subset analysis in patients 1 and 3
Patient 1 Patient 3 Reference
White cell count
 ×109/L 4.3 4.10 4.0–11.0
Lymphocytes
 % 3 12 20–45
CD3+[T cell]
 cells/μL 16 399 1100–1700
 % 58 81 67–76
CD3+CD4+(T helper)
 cells/μL 12 166 700–1100
 % 46 33 38–40
CD3+CD8 (T suppressor)
 cells/μL 4 210 500–900
 % 13 42 31–40
CD19+(B cells)
 cells/μL 9 58 200–400
 % 33 12 11–16
CD16+CD56+(NK)
 cells/μL 1.0 26 200–400
 % 5 5 10–19
CD4/CD8 ratio 3.54 0.79 1–1.5
500 Y. M. Arabi et al.
1 3
the respiratory tract, and had lymphopenia with a profound 
depression of T and B lymphocyte subsets. So the neuro-
logic syndrome in the context of severe MERS-CoV infec-
tion and the distinct imaging patterns suggest that MERS-
CoV infection may be responsible for the extensive CNS 
injury observed in our patients.
Although the clinical, radiological, and laboratory find-
ings were suggestive of MERS-CoV associated neurological 
illness, several differential diagnoses were considered, given 
the lack of confirmatory test of brain infection namely the 
presence of corona virus in the brain tissue and/or in the CSF. 
In addition, the use of sedation as part of the management of 
severe ARDS may have masked the onset or the progression 
of neurologic manifestations. Because of the presence of risk 
factors, acute ischemic stroke was first sought but ruled out 
by brain imaging, except for patient 2. Other potential expla-
nations to the neurologic findings such as air and fat embo-
lism, or post-anoxic damage were also considered, although 
less likely. The two patients requiring high ventilator settings 
did not exhibit any evidence of barotrauma. Fat embolism 
appears unlikely given the lack of risk factors. None of the 
patient had sustained cardiovascular arrest. Although one 
of the patients had severe hypoxemia, it was not associated 
with neurologic abnormalities and resolved after intuba-
tion. Moreover, the MRI findings did not follow the typical 
changes associated neither with hypoxia–ischemia. Indeed, 
brain MRI of patient 1 is rather supportive of a viral etiology, 
more specifically of an acute disseminated encephalomyelitis 
(ADEM) [6], an immune mediated disease that often occurs 
following viral infection [7]. It is also consistent with enceph-
alitis, albeit less probably due to the predominant white mat-
ter involvement and the striking restricted diffusion. In patient 
two, the MRI findings were suggestive of bilateral anterior 
cerebral artery stroke. It is known that patients with cardio-
vascular risk factors are at high risk of developing a cerebral 
stroke during sepsis or during their hospitalization in an ICU, 
independently to the etiology of the sepsis or the cause of 
admission to an ICU. However, in our case the CT angio-
gram performed after the onset of neurologic deficits showed 
patent ACAs. Stroke caused by viral vasculopathy has been 
described with other viruses including varicella zoster virus, 
cytomegalovirus, and human immunodeficiency virus [8]. 
Therefore, it is conceivable that the observed non-occlusive 
stroke and myocardial infraction are associated with MERS-
CoV vasculopathy.
MERS-CoV is one of the human corona viruses that 
include also five other strains: SARS-CoV, HCoV-OC43, 
HCoV-229E, HCoV-NL-63, and HCoV-HKU1. Although 
corona viruses are generally known for causing respiratory 
illness, both clinical and experimental studies have demon-
strated their strong tropism to the CNS [9–15]. SARS-CoV 
infection induced in mice model results in neuronal death 
without encephalitis [16]. Brain necropsy study in eight 
confirmed cases of SARS revealed direct viral infection 
of neuronal cells located in the cortex and hypothalamus 
[17] with edema and scattered red degeneration suggest-
ing neuronal ischemia type of injury. Laboratory studies 
have shown that HCoV-OC43 and HCoV-229E also have 
the ability to infect human neural cells including neurons 
and glial cells [12, 13, 18–20]. In addition, HCoV-OC43 
has been detected in the CSF of a child with ADEM. Direct 
evidence that MERS-CoV is the cause of CNS damage 
observed in our patients is difficult to ascertain due to the 
lack of brain pathology samples. Our patients were severely 
ill, and no effective therapy exists to justify further invasive 
diagnostic approach. The negative CSF for MERS-CoV 
RT-PCR may be due to the timing of the test, the lack of 
meningeal involvement as shown on MRI or that the virus 
is intra-neuronal as reported with SARS-CoV [21].
To the best of our knowledge, no neurologic involve-
ment with MERS-CoV has been so far reported. Hence, 
our cases raise important questions. What are the patho-
genic mechanisms that underlie the occurrence of neuro-
logic injury in our patients? In other words, is it related to 
specific host factors in these patients or related to a newly 
acquired virulence leading to neurotropism of the MERS-
CoV? [9, 13] One interesting question raised from these 
cases is whether there is a link between the observed lym-
phopenia and the observed neurologic manifestations. The 
receptor for MERS-CoV was recently identified as dipepti-
dyl peptidase-4 (DPP4, also known as CD26) [22]. DPP4 is 
expressed on T-cells and in the lung, kidney, placenta, liver, 
skeletal muscle, heart, brain, endothelium, and pancreas 
[23]. The presence of these receptors may be linked to their 
susceptibility of these organs, including the brain, to infec-
tion [24] but this needs further study.
Conclusion
MERS-CoV infection causes multiple organ damage 
including pulmonary, cardiovascular, renal, coagulation, 
gastrointestinal tract, and muscles. Our observation sug-
gests that CNS may be another target of MERS-CoV infec-
tion, and thus should be considered in any patients with 
progressive or worsening CNS findings.
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